Tag: Dana-Farber Cancer Institute
Lexicon Pharmaceuticals, Inc. Clinical Trial Recruiting Carcinoid Syndrome Patients
September 10, 2010
Patients with carcinoid syndrome, whose symptoms are not managed by octreotide therapy, are being recruited for a Phase 2 clinical trial of Lexicon Pharmaceuticals’ LX1606 (a.k.a. LX1032). The trial has been given Fast Track status in the U.S. and …
READ MORE
Clinical Trials Resources for Carcinoid Cancer & Neuroendocrine Tumor Patients
June 13, 2010
Carcinoid and neuroendocrine tumor patients can have the latest information about clinical trials delivered directly to their computers – by RSS feed or e-mail. Go to https://clinicaltrials.gov/, in the search field enter the type of trial you are…
READ MORE
